

Press Releases
The latest news from StrideBio.
February 4, 2022 • Research Triangle Park, N.C.
Research Triangle Park, N.C., February 4, 2022 – StrideBio, Inc., a leading developer of novel adeno-associated viral (AAV) based gene therapies, today announced the appointment ...
October 4, 2021 • Research Triangle Park, N.C.
100th team member hired, bolstering internal capabilities from capsid platform to clinic with an emphasis on in-house manufacturing capability Completed construction of GMP manufacturing facility ...
June 15, 2021 • Research Triangle Park, N.C.
Newly created roles will support StrideBio’s operations across strategy, regulatory affairs, quality, and patient advocacy Research Triangle Park, N.C., June 15, 2021 – StrideBio, Inc., ...
April 27, 2021 • Research Triangle Park, NC
Research Triangle Park, N.C., April 27, 2021 – StrideBio, Inc., a leading developer of novel adeno-associated viral (AAV) based gene therapies, today announced the appointment ...
April 14, 2021 • Research Triangle Park, NC
StrideBio receives exclusive license to novel cross-species evolved AAV vectors and an enzymatic approach for neutralizing antibody evasion Master Sponsored Research Agreement will support collaborative ...
March 16, 2021 • Research Triangle Park, NC
Proceeds to advance structure-guided AAV capsid engineering platform and pipeline of novel gene therapy candidates into the clinic, including four new wholly-owned programs Financing will ...
